【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Drug Delivery Infusion Systems Overview 12
3 Products under Development 14
3.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 14
3.2 Drug Delivery Infusion Systems – Pipeline Products by Segment 15
3.3 Drug Delivery Infusion Systems – Pipeline Products by Territory 16
3.4 Drug Delivery Infusion Systems – Pipeline Products by Regulatory Path 17
3.5 Drug Delivery Infusion Systems – Pipeline Products by Estimated Approval Date 18
3.6 Drug Delivery Infusion Systems – Ongoing Clinical Trials 19
4 Drug Delivery Infusion Systems – Pipeline Products under Development by Companies 20
4.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 20
4.2 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 22
5 Drug Delivery Infusion Systems Companies and Product Overview 24
5.1 410 Medical Innovation, LLC Company Overview 24
5.1.1 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.2 Acuros GmbH Company Overview 25
5.2.1 Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 AktiVax Inc. Company Overview 26
5.3.1 AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Alnylam Pharmaceuticals, Inc. Company Overview 27
5.4.1 Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Anesthesia Safety Products, LLC Company Overview 29
5.5.1 Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 AngioDynamics, Inc. Company Overview 30
5.6.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Automedics Medical Systems Company Overview 34
5.7.1 Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 34
5.8 Baxter International Inc. Company Overview 35
5.8.1 Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 BioCardia, Inc. Company Overview 36
5.9.1 BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Debiotech S.A. Company Overview 38
5.10.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Delpor, Inc. Company Overview 40
5.11.1 Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Edwards Lifesciences Corporation Company Overview 42
5.12.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 Eksigent Technologies, LLC Company Overview 43
5.13.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.14 Eli Lilly and Company Company Overview 45
5.14.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 Flowonix Medical, Inc. Company Overview 47
5.15.1 Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 FluidSynchrony, LLC Company Overview 48
5.16.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Fluonic, Inc. Company Overview 49
5.17.1 Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Fresenius Kidney Care Company Overview 50
5.18.1 Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 Imagnus Biomedical Inc. Company Overview 51
5.19.1 Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Innovfusion Pte. Ltd. Company Overview 52
5.20.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.21 Intarcia Therapeutics, Inc. Company Overview 55
5.21.1 Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 IRadimed Corporation Company Overview 59
5.22.1 IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
5.23 Ivenix, Inc. Company Overview 61
5.23.1 Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.24 LifeMedix, LLC Company Overview 63
5.24.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
5.25 Lynntech, Inc. Company Overview 64
5.25.1 Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.26 Medallion Therapeutics, Inc. Company Overview 65
5.26.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.27 Medical Device Creations Ltd. Company Overview 66
5.27.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.28 MedPrime Technologies Pvt. Ltd. Company Overview 67
5.28.1 MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
5.29 Mercator MedSystems, Inc. Company Overview 68
5.29.1 Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.30 Nano Precision Medical Company Overview 72
5.30.1 Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 72
5.31 NexGen Medical Systems, Inc. Company Overview 73
5.31.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 Nipro Corporation Company Overview 74
5.32.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Owen Mumford Limited Company Overview 76
5.33.1 Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 Pavmed Inc Company Overview 77
5.34.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.35 PRO-IV Medical Ltd. Company Overview 78
5.35.1 PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
5.36 Ratio, Inc. Company Overview 81
5.36.1 Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.37 Rice University Company Overview 82
5.37.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 82
5.38 SteadyMed Therapeutics, Inc. Company Overview 83
5.38.1 SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.39 StnDrd Infusion Corporation Company Overview 85
5.39.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.40 Tel Aviv University Company Overview 87
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 87
5.41 Terumo Corporation Company Overview 88
5.41.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 88
5.42 ToucheMedical Ltd. Company Overview 90
5.42.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 90
5.43 Unilife Corporation Company Overview 91
5.43.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 91
5.44 University of Minnesota Company Overview 93
5.44.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 93
5.45 University of Southern California Company Overview 95
5.45.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95
6 Drug Delivery Infusion Systems – Recent Developments 96
6.1 Jun 16, 2016: Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate within the First Month of Implementation 96
6.2 Jun 14, 2016: IRADIMED Announces Election of Roger Susi as Chairman of the Board 96
6.3 Jun 13, 2016: Aarti Shah named chief information officer 97
6.4 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 97
6.5 Jun 09, 2016: IRADIMED Provides Regulatory Update 99
6.6 Jun 07, 2016: Intarcia Announces Branding of the Medici Drug Delivery System- A Platform of Technologies Key to Advancing its Pipeline of Once-Yearly Peptide and Antibody Fragment-Based Therapeutics in Poorly Controlled Chronic Diseases 100
6.7 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 100
6.8 Jun 03, 2016: Autostart Burette Listed Through Qld Health Tender 101
6.9 Jun 01, 2016: Phillips-Medisize Acquires Medicom Innovation Partner 101
6.10 Jun 01, 2016: Flowonix Medical Raises USD10.5 Million in Venture Financing 102
6.11 Jun 01, 2016: Flowonix Medical Secures USD5 Million in Venture Debt Financing 102
6.12 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 102
6.13 May 24, 2016: Pyng Medical Reports Second Quarter Fiscal 2016 Results 104
6.14 May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community 105
6.15 May 23, 2016: Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision With Iluvien At 12 Months 106
6.16 May 23, 2016: Unilife Announces Receipt of Deficiency Letter from NASDAQ 107
6.17 May 18, 2016: Study Finds 90 Percent of Pump Programming Events for High-Alert Infusion Medications are Dose Adjustments 107
6.18 May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO 108
6.19 May 18, 2016: Repro Med Systems Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors 109
6.20 May 16, 2016: B. Braun to Showcase Its Innovative Synchronized Intelligence Infusion Platform at AACN 110
6.21 May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO 110
6.22 May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results 111
6.23 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 111
6.24 May 11, 2016: Steadymed Provides Corporate Update And Reports First Quarter 2016 Financial Results 111
6.25 May 10, 2016: B. Braun Medical Calls for ECRI Institute to Establish a Scientific, Protocol-Driven Methodology for Evaluating Infusion Pumps 112
6.26 May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 113
6.27 May 06, 2016: Alimera Sciences’ ILUVIEN Data Presented At 2016 ARVO 114
6.28 May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes 115
6.29 May 03, 2016: Strong start into the year – Double-digit earnings growth in constant currency – Fresenius confirms Group guidance for 2016 116
6.30 Apr 29, 2016: IRADIMED Announces First Quarter 2016 Financial Results 118
6.31 Apr 15, 2016: InfuSystem to Acquire Infusion Pump Assets from InfusAID 119
6.32 Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building 120
6.33 Apr 01, 2016: IRADIMED Provides Regulatory Update 120
6.34 Mar 29, 2016: Hicks Thomas Represents EMED Technologies Seeking Injunction against RMS Medical Products for Infusion Devices FDA Warns Are Adulterated and Misbranded 120
6.35 Mar 15, 2016: Zyno Medical to Feature Z-800F Set Based Anti-Free-Flow IV Pump at NHIA 121
6.36 Mar 09, 2016: Repro Med Systems Responds to FDA Warning Letter 121
6.37 Feb 26, 2016: Zyno Medical to Feature ZynoFlo Integrated Infusion System at ACCC 121
6.38 Feb 26, 2016: Zyno Medical to Feature Z-800WF IV Infusion Pump at ACCC 122
6.39 Feb 24, 2016: Alaris System Named 2015 Best In KLAS for Smart Pumps 122
6.40 Feb 24, 2016: Outstanding 2015 financial results – 25% dividend increase proposed – Positive outlook for 2016 – New mid-term growth targets 123
6.41 Feb 24, 2016: Aetna and Roxborough Memorial Hospital Agree to Three-Year Contract 127
6.42 Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director 128
6.43 Feb 05, 2016: IRADIMED Announces Fourth Quarter 2015 Financial Results 128
6.44 Jan 21, 2016: Mercator MedSystems Announces First Patient Enrolled in Below the Knee Clinical Trial 129
6.45 Jan 20, 2016: LifeFlow Rapid Infuser Receives Innovation Award at Pediatrics 2040 Meeting 130
6.46 Jan 13, 2016: Pfizer May Sell Infusion Pump Business of Hospira 130
6.47 Jan 11, 2016: IRADIMED Announces 2016 Annual and First Quarter Financial Guidance 131
6.48 Jan 06, 2016: Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer 131
6.49 Dec 10, 2015: IRADIMED Updates Status of 510(k) Submission 132
6.50 Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing 132
6.51 Nov 05, 2015: Surefire Medical Raises Additional USD4 Million in Venture Financing 132
6.52 Nov 03, 2015: IRadimed Plans to Raise up to USD40 Million in Public Offering of Shares 133
6.53 Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT 133
6.54 Oct 30, 2015: IRADIMED Announces Third Quarter 2015 Financial Results 133
6.55 Oct 30, 2015: IRADIMED Announces Dismissal of Appeal 134
6.56 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting 134
6.57 Oct 23, 2015: Edwards Lifesciences Enters into Agreement with CareFusion 135
6.58 Oct 08, 2015: Smiths Medical Awarded Contract by Novation 135
6.59 Oct 08, 2015: Bespak Launches New Brand Identity To The Market 136
6.60 Oct 05, 2015: Medicom receives the growth award – Borsen Gazelle 2015 136
6.61 Sep 25, 2015: Surefire Medical Introduces New Precision Infusion System 136
6.62 Sep 22, 2015: B. Braun Receives FDA Clearance for Infusomat Space Pump 137
6.63 Sep 03, 2015: pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation’s BioInterface 2015 Annual Symposium 138
6.64 Sep 01, 2015: Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device 138
6.65 Aug 27, 2015: Hospira Announces First Installation of Plum 360 Infusion System With Hospira MedNet 138
6.66 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President 139
6.67 Jul 31, 2015: Symbiq Infusion System by Hospira: FDA Safety Communication – Cybersecurity Vulnerabilities 140
6.68 Jul 30, 2015: IRADIMED Announces Second Quarter 2015 Financial Results 140
6.69 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 141
6.70 Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 142
6.71 Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders 143
6.72 Jul 08, 2015: MicroPort Lifesciences Attends Diabetes and Gonadal Disorders Meeting to Promote La Fenice 144
7 Appendix 145
7.1 Methodology 145
7.2 About GlobalData 147
7.3 Contact Us 148
7.4 Disclaimer 148
【レポート販売概要】
■ タイトル:世界の薬物送達注入装置市場:医療機器パイプライン分析2016■ 英文:Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016
■ 発行日:2016年7月4日
■ 調査会社:GlobalData
■ 商品コード:GDME0209EPD
■ 調査対象地域:グローバル
- 世界のスマートドアベルカメラ市場:製品別、地域別Global Smart Doorbell Camera Market: About this market Technavio’s smart doorbell camera market analysis considers sales from both stand-alone and integrated products. Our study also finds the sales of smart doorbell camera in APAC, Europe, MEA, North America, and South America. In 2019, the stand-alone segment had a significant market share, and this trend is expected to continue over the forecas …
- 泌尿器科用機器の世界市場予測(~2026):尿失禁、良性前立腺過形成(BPH)、腎臓結石、前立腺がんThe global urology devices market is expected to grow at a CAGR of 5.8% from 2020-2026 and CAGR of 6.2% from 2016-2020. The market is expected to grow at a CAGR of 6.0% from 2016 to 2026. The market is estimated at $6,126.4 million in 2016, $7,793.0 million in 2020, and $10,971.3 million in 2026. How this report will benefit you Read on to discover how you can exploit the future business opportuni …
- 感染対策の世界市場予測・分析2020-2024Global Infection Control Market: About this market Technavio’s infection control market analysis considers sales from both therapeutic and non-therapeutic types. Our study also finds the sales of infection control in Asia, Europe, North America, and ROW. In 2019, the therapeutic segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as …
- 自動車用エンジンベルト/ホースの世界市場:エンジンベルト(タイミングベルト、ドライブベルト)、ホース(ターボチャージャー、冷却/暖房、燃料供給、ブレーキ、ステアリング)The global market for automotive belts & hoses is estimated to grow at CAGRs of 6.09% and 6.82% respectively from 2015 to 2020. The market for automotive belts & hoses is primarily propelled by increasing vehicle production, increasing adoption of turbochargers in the vehicles, stringent fuel emission norms and regulations, and the rising demand for fuel efficient technologies. However, shifting f …
- 鋼線ロープ&プラスチックロープの世界市場予測(~2024年)“The steel wire rope & plastic rope market is projected to register a CAGR of 5.0% during the forecast period.”The steel wire rope & plastic rope market is expected to grow from USD 11.3 billion in 2019 to USD 14.5 billion by 2024, at a CAGR of 5.0% during the forecast period. New product launches leading to an increased application scope of steel wire rope & plastic rope as well as the growing us …
- Market Opportunity Service Delivery Platforms (SDP)Service Delivery Platform (SDP) can be loosely defined as a standards based framework that facilitates the design, development, implementation and management of services required to run the operations of network services providers. The services could range from the basic voice connectivity to the state-of-the-art rich multimedia services. SDP systems represent a cost effective, efficient choice fo …
- 世界における小型自動車用OE(メーカー純正部品)排気装置市場動向と予測(~2029)This latest just-auto report edition offers a global review of the OE automotive exhaust systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE exhaust systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their str …
- 世界のナノサテライト&マイクロサテライト市場:コンポーネント別(ハードウェア、ソフトウェアおよびデータ処理、起動サービス)、種類別(ナノサテライトおよびマイクロサテライト)、用途別、業種別(政府、防衛、民事)、地域別The global nanosatellite and microsatellite market size to grow at a CAGR of 19.8% during the forecast period The global nanosatellite and microsatellite market size is expected to grow from USD 1.5 billion in 2019 to USD 3.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 19.8% during the forecast period. The satellites are used for several applications, such as communication, earth o …
- 世界のオレオケミカル市場2015The Global Oleochemicals Industry Report 2015 is a professional and in-depth study on the current state of the Oleochemicals industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Oleochemicals market analysis is provided for the international markets including development trends, competitive landscape a …
- インフルエンザ検査の世界市場2015The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals &nb …
- 地域冷房の世界市場予測(~2021年):フリークーリング、吸収冷却、電動式チラー“Increasing demand for cooling and energy-efficient cooling technologies across the globe to drive the market for district cooling.” The global market for district cooling is projected to grow from USD 5.14 billion in 2016 to USD 9.54 billion by 2021, at a CAGR of 13.19% from 2016 to 2021. Rising energy prices, growing environmental concerns, and rising demand for low cost and high-efficiency cool …
- 女性の性的欲求低下障害(Female Hypoactive Sexual Desire Disorder)の治療薬パイプライン動向(2015年上半期版)Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015’, provides an overview of the Female Hypoactive Sexual Desire Disorder’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete wi …
- グローバル装甲車・対IED防御車両市場(2014-2024):地域別分析Synopsis This report offers detailed analysis of the global Armored and Counter IED Vehicles market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Armored and Counter IED Vehicles market. Summary "The Global Armored and Counter IED Vehicles Market 2014-2024 - Country Analysis: Market Profile" …
- 世界のトランスオイル(変圧器油)市場(~2018)This report estimates the transformer oil market in terms of volume and value. The volume market is estimated in terms of the demand of the transformer oil per year. The report estimates the market size of the transformer oil industry for product types such as mineral oil which is further classified into naphthenic and paraffinic; silicone, and bio-based transformer oils. This has been broken down …
- 免疫調節剤の世界市場分析:製品別(免疫抑制剤、免疫刺激剤、ワクチン、抗体)、用途別(腫瘍学、呼吸器、HIV)、地域別、セグメント予測、2014-2025The global immunomodulators market is expected to reach USD 233.7 billion by 2025, according to a new study by Grand View Research, Inc. The market is anticipated to be predominantly driven by high R&D investments employed by the prominent companies, resulting into the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedente …